Evidence map›Paper›PMID 30094720›Full record

ArticleJournal of neuro-oncology2018

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.

Nooshin Hashemi-Sadraei, Gaëlle M Müller-Greven, Fadi W Abdul-Karim, Ilya Ulasov, Erinn Downs-Kelly, Monica E Burgett, Adam Lauko, Maha A Qadan, Robert J Weil, Manmeet S Ahluwalia and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Nooshin Hashemi-SadraeiDepartment of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Gaëlle M Müller-GrevenDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
Fadi W Abdul-KarimDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Ilya UlasovDepartment of Medicine, Section of Neurological Surgery, The University of Chicago, Chicago, IL, USA.
Erinn Downs-KellyDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Monica E BurgettDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
Adam LaukoDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
Maha A QadanDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA.
Robert J WeilBrain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
Manmeet S AhluwaliaBrain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA.
Lingling DuDepartment of Medicine, Cleveland Clinic, Cleveland, OH, USA.
Richard A PraysonDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Samuel T ChaoDepartment of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA.
Thomas G BuddDepartment of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Jill Barnholtz-SloanDivision of General Medical Sciences-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Amy S NowackiQuantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Ruth A KeriDivision of General Medical Sciences-Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Candece L GladsonDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NB40, Cleveland, OH, 44195, USA. gladsoc@ccf.org.ORCID http://orcid.org/0000-0002-7651-4046
Cleveland Clinic · USCleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USUniversity of Chicago · USUniversity School · US

Funding

Mechanisms Promoting Angiogenesis in GlioblastomaR01CA175120 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI GLADSON, CANDECE L · 2013 to 2017
$1.7M
Brain Endothelial TNF-R1 Can Function to Inhibit AngiogenesisR01CA152883 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI GLADSON, CANDECE L · 2010 to 2014
$1.6M
Cleveland Clinic Foundation RPC 2010-1070-R1NCI NIH HHS R01 CA152883NCI NIH HHS R01 CA175120NIH HHS R01-CA152883NIH HHS R01-CA175120
6 · The paper itself

Abstract

backgroundMacroautophagy/autophagy is considered to play key roles in tumor cell evasion of therapy and establishment of metastases in breast cancer. High expression of LC3, a residual autophagy marker, in primary breast tumors has been associated with metastatic disease and poor outcome. FIP200/Atg17, a multi-functional pro-survival molecule required for autophagy, has been implicated in brain metastases in experimental models. However, expression of these proteins has not been examined in brain metastases from patients with breast cancer.

methodsIn this retrospective study, specimens from 44 patients with brain metastases of infiltrating ductal carcinoma of the breast (IDC), unpaired samples from 52 patients with primary IDC (primary-BC) and 16 matched-paired samples were analyzed for LC3 puncta, expression of FIP200/Atg17, and p62 staining.

resultsLC3-puncta

conclusionsThese results support assessments of precision medicine-guided targeting of autophagy in treatment of brain metastases in breast cancer patients.

Indexed as

AdultAgedAutophagy-Related ProteinsBiomarkers, TumorBrainBrain NeoplasmsBreast NeoplasmsCarcinoma, Ductal, BreastFemaleGene Expression Regulation, NeoplasticHumansMeta-Analysis as TopicMicrotubule-Associated ProteinsMiddle AgedProtein-Tyrosine KinasesRetrospective StudiesAutophagy-Related ProteinsBiomarkers, TumorMAP1LC3B protein, humanMicrotubule-Associated ProteinsProtein-Tyrosine KinasesRB1CC1 protein, humanRNA, MessengerAutophagyBrain metastases of breast cancerFIP200/Atg17LC3RecurrenceSurvival

Identifiers

PMID30094720
OpenAlexW2886665139

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.